Article Data

  • Views 366
  • Dowloads 106

Case Reports

Open Access

Primary fallopian tube carcinoma - case report

  • V. Pažin1,2
  • A. Dobrosavljevic2,*,
  • L. Nejkovic1,2

1Medical faculty University of Belgrade, Belgrade, Serbia

2Clinic of Obstetrics and Gynecology “Narodni Front”, Belgrade, Serbia

DOI: 10.12892/ejgo4417.2019 Vol.40,Issue 1,February 2019 pp.163-165

Accepted: 14 September 2017

Published: 10 February 2019

*Corresponding Author(s): A. Dobrosavljevic E-mail:


Primary fallopian tube carcinoma is a rare gynecological malignancy and it accounts for about 1% of all gynecological malignancies. Etiological factors are not sufficiently known, but most commonly specified are infertility, nulliparity, and pelvic inflammatory disorder. It is most often asymptomatic, although, a triad reported by Latzko including a vaginal watery discharge, colic like pelvic pain, presence of tumor mass in pelvis, is mentioned as pathognomonic. In the present case, it was primary fallopian tube carcinoma, in FIGO Stage IA. After complete abdominal hysterectomy with lymph node dissection, in line with the expert council’s decision, no adjuvant chemotherapy was administered. PET CT in June 2017, two years after the surgical treatment, presented both some metastatic changes in lungs and enlarged retroperitoneal lymph nodes and after this finding, and chemotherapy with carboplatin was begun. The therapy implies surgical treatment being hysterectomy with adnexectomy, but also retroperitoneal lymph node dissection as well, considering that it more often affects lymphatic glands than epithelial ovarian cancer (EOC). It can be misinterpreted with EOC in a pathological sense. In addition to a surgical treatment, the most common form of chemotherapy is platinum-combined with taxanes.


Fallopian tube carcinoma; Epithelial ovarian cancer, Pelvic inflammatory disorder; Chemotherapy; Platinum; Taxanes

Cite and Share

V. Pažin,A. Dobrosavljevic,L. Nejkovic. Primary fallopian tube carcinoma - case report. European Journal of Gynaecological Oncology. 2019. 40(1);163-165.


[1] Kalampokas E., Kalampokas T., Tourountous I.: “Primary fallopian tube carcinoma”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 169, 155.

[2] Wang P.H., Liu R.S., Li Y.F., Ng H.T., Yuan C.C.: “Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: An initial report”. Gynecol. Oncol., 2000, 77, 44.

[3] King A., Seraj I.M., Thrasher T., Slater J., Wagner R.J.: “Fallopian tube carcinoma: aclinicopathological study of 17 cases”. Gynecol. Oncol., 1989, 33, 351.

[4] Riska A., Lemien A.: “Updating on primary fallopian tube carcinoma”. Acta Obstet. Gynecol. Scand., 2007, 85, 1419.

[5] Jurgen M.J.P., Paul J.V.D., Ronald P.Z., Jan W.J., Ria J.J.P.K, Fred H.M., et al.: “Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer”. J. Pathol., 2001, 195, 451.

[6] Lawson F., Lees C., Kelleher C.: “Primary cancer of fallopian tube”. In: Studd J. (ed). Progress in Obstetrics and Gynecology. London, UK: Churchill Livingstone, 1996, 393.

[7] Kietpeerakool C., Suprasert P., Srisomboon J., Pantusart A.: “Primary carcinoma of fallopian tube: A clinicopathologic analysis of 27 patients”. J. Med. Assoc. Thai., 2005, 88, 1338.

[8] Pectasides D., Pectasides E., Econompoulus T.: “Fallopian tube carcinoma: a review”. Oncologist, 2006, 11, 902.

[9] Rose P., Piver M.S, Tsuleada Y.: “Fallopian tube cancer – The Rosewell Park experience”. Cancer, 1990, 66, 2661.

[10] Gunter J.: “Chronic pelvic pain: An integrated approach to diagnosis and treatment”. Obstet. Gynecol. Surv., 2003, 58, 615.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time